NCT00589732 - Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Coronary Artery Disease

Interventions

DRUG

Valsartan

Valsartan 160mg per day

Trial Locations (5)

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

St. Mary's Catholic Medical Center, Seoul

Yonsei University Medical Center, Seoul

Ajou University Hospital, Suwon